Article Detail

Home > Article Detail
  • P-ISSN 1010-0695
  • E-ISSN 2288-3339

Analysis of Survival in 273 Terminally Ill Cancer Patients Treated with Traditional Oriental Therapies

Journal of Korean Medicine / Journal of Korean Medicine, (P)1010-0695; (E)2288-3339
2004, v.25 no.4, pp.152-160
Jung-Hyo Cho

Chang-Gue Son
Yeon-Weol Lee
Hwa-Seung Yoo
Nam-Heon Lee
Dam-Hee Yun
Chong-Kwan Cho
  • Downloaded
  • Viewed

Abstract

Objective: Recently, an increasing portion of cancer patients use various therapies of complementary and alternative medicine (CAM) including traditional oriental medicine, which is believed to improve the consequence of cancer according to clinical experience and laboratory data. But the clinical-based systemic statistic validity of these therapies is lacking, so this study was aimed to validate the traditional oriental therapies (TOT) for terminally ill cancer patients. Patients and methods This retrospective study was performed on 273 patients who were diagnosed with terminally ill cancer in Korea and treated with TOT in the oriental hospital of Daejeon University, from March 1997 to June 2003. We examined the median duration of the terminal period and the correlations between 9 factors and survival of terminally ill cancer patients. Results During the study period, we could confirm 142 patients' death (52.01%) in 273 subjects. The median length of survival in terminally ill cancer patients was 16 weeks (95%CI 14.0~20.0) and 40.15% (95%CI 40.07~40.22) of patients had survived more than 24 weeks. According to Cox's proportional hazard model including gender, age, conventional therapies (chemotherapy, radiotherapy and surgery), performance status and clinical symptoms as independent variables, history of conventional therapies (RR 0.581, 95%CI 0.381~0.885), higher performance status (RR 1.855, 95%CI 1.454~2.366) and absence of ascites and pleural effusion (RR 1.631, 95%CI 1.047~2.538) showed independent prognostic value of survival. Conclusion Our findings suggest that TOT offer potential benefits for cancer patients at the terminal stage.

keywords
Terminally ill cancer, Survival, Traditional oriental therapies (TOT), Terminally ill cancer, Survival, Traditional oriental therapies (TOT)


Reference

1

(2003) Complementary and alternative medicine (CAM) use among elderly Australian women who have cancer,

2

Why are cancer patients using non-proven complementary therapies? A cross-sectional multicentre study in Norway,

3

(1998) Why patients use alternative medicine: results of a national study,

4

(2001) Study on the anti-angiogenic therapy to cancer disease with oriental medicine,

5

(2001) A study on recent tendency of anti-tumor herbal acupuncture,

6

(2002) A study on cancer therapy of activating blood circulation and congestion .,

7

(1997) Effect of hangambujeongtang on the reticuloendothelial system blocking by silica and the immune depression induced by 5-FU in mice. The thesis collection of the 19th annual convention of Korean Orient Med 1997;19,

8

(2003) Introduction of hemopoiesis by Saeenghyuldan a mixture of Ginseng Radix, Paeoniae Radix Alba, and Hominis Placenta extracts. ,

9

(2001) Clinical study in 67 cases of hepatoma patients by Oriental medicine,

10

(2001) The clinical study in 60 cases for breast cancer patients on the effects by Hangamadan,

11

(2001) The clinical report of PSM about 121 cancer patients,

12

(2000) The clinical study in 83 cases for colorectal cancer patients on the effects by Hangamdan,

13

(2001) Social worker estimations of life span in terminal cancer patients,

14

(2000) Terminal cancer: duration and prediction of survival time. ,

15

(1996) Survival of Medicare patients after enrollment in hospice programs,

16

(1998) Retrospective cohort study of survival and prognostic factors in patients with terminal cancer,

17

(1996) Prognostic value of quality of life scores in terminal cancer patients,

18

Evaluation of patients with advanced cancer using the Karnofsky performance status scale an examination of its reliability and validity in a research setting,

19

Clinical symptoms and length of survival in patients with terminal cancer,

20

a key element in cancer rehabilitation,

21

Biological indices predictive of survival in 519 Italian terminally ill cancer patients,

22

(1995) Estimating length of survival in end-stage cancer A review of the literature,

23

(2001) How accurate are physicians' clinical predictions of survival and the available prognostic tools in estimating survival times in terminally ill cancer patients? A systemic review,

24

(1998) Accuracy of prediction of survival by different professional groups in a hospice,

25

(1999) The relative accuracy of the clinical estimation of the duration of life for patients with end of life cancer,

26

(1999) Successful validation of the patient' prognostic score in terminally ill cancer patients Italian Multicentre Study Group on Palliative Care,

27

(2003) Dose use of alternative medicine predict survival from cancer?,

28

(1996) Alternative and complementary cancer treatments,

29

Estimate of survival of patients admitted to a palliative care unit: a prospective study.,

30

Can unorthodox cancer therapy improve quality of life? Ann Oncol 1993;4,

31

(1998) Cancer patients use of nonproven therapy: a 5-year follow-up study,

32

(2000) Use of complementary and alternative medicine by cancer patients is not associated with perceived distress or poor compliance with standard treatment but with active coping behavior,

33

(2003) Use of alternative medicine by patients with cancer in a rural area of Switzerland,

34

(2000) Extent and determinant of error in doctor' prognoses in terminally ill patients:prospective cohort study,

35

(2000) Commentary: Why do doctors overestimate?,

  • Downloaded
  • Viewed
  • 0KCI Citations
  • 0WOS Citations

Other articles from this issue

Recommanded Articles

상단으로 이동

Journal of Korean Medicine